Year: 2026

India is one of the world’s largest sources of generic APIs, so buyers have plenty of choice. That is both an advantage and a risk, because quality, transparency and reliability differ widely between suppliers. If you want to choose an API manufacturer in India, you need a clear way to separate dependable manufacturers from traders, middlemen and weak operators. This guide focuses on the India-specific points: how to verify licences and certificates, where manufacturers are located, what regulators check, and what to look for in export readiness. Key Takeaways Verify the manufacturing site, licence and GMP certificate, and make sure they all refer to the same site. Know whether you are dealing with a manufacturer, a trader or a contract manufacturer. Check export experience, documentation quality and regulatory inspection history. Ask about raw material and key starting material sourcing, because some inputs are imported.   Why Buyers Source APIs from India India has a large API and generics ecosystem, with chemists, intermediates and equipment suppliers close together, plus manufacturing cost advantages and wide export experience. Bulk drug exports were about US$4.87 billion in FY2024-25, according to Pharmexcil. See our guide to the pharmaceutical industry in India for the wider picture. Step 1: Confirm Who the Manufacturer Is In India’s API market you may speak to a manufacturer, a trader sourcing from several plants, or a company with its own and partner sites. All can be legitimate, but traceability matters. Ask: Who is the actual manufacturer of this API? Where is the manufacturing site, and can I see its address on the licence and the CoA? Which products do you make yourselves, and which do you source? Step 2: Verify Licences and Certificates Manufacturing licence: in India, manufacturing licences are issued by the state licensing authority under the Drugs and Cosmetics Rules. Ask for a copy and check that the site and product are covered. GMP certification: ask for the current certificate (for example WHO-GMP) and check the issuing authority, validity date and site address. Other certificates: ISO or similar certificates are useful but do not replace GMP. Check that names and addresses are consistent across the licence, the GMP certificate and the Certificate of Analysis. Where possible, confirm authenticity with the issuing authority. See GMP in pharmaceutical manufacturing. Step 3: Check Inspection and Regulatory History Ask which regulators have inspected the site and what the outcomes were. Some buyers also review public inspection records and warning letters from major regulators. A clean record is not a guarantee, but repeated serious observations are a red flag. Step 4: Review the Documents A serious manufacturer can provide a Certificate of Analysis, specification, impurity and stability data, Safety Data Sheet and regulatory support such as DMF information. See documents to request from an API supplier, what a CoA is and what a DMF is. Step 5: Ask About Raw Material Sourcing India is a large API producer but still imports some key starting materials and intermediates, mainly from China. Ask where critical inputs come from, whether there are backup suppliers and how the supplier would handle a disruption. This protects your supply continuity. Step 6: Test Samples and Consider an Audit Test a sample against your own specification before committing. For critical products, an on-site or remote audit lets you see the facility, quality systems and practices. See how to evaluate a pharmaceutical API supplier. Step 7: Check Export Readiness For international buyers, also confirm: experience exporting to your region and with your regulator’s requirements packaging suitable for long-distance transport and your climate shipping documents, labelling and agreed delivery terms reliable communication, response time and after-sales support Where Are Indian API Manufacturers Located? Manufacturers are spread across the country, with well-known clusters in states such as Gujarat, Telangana, Andhra Pradesh, Maharashtra and Himachal Pradesh. Location itself does not decide quality, but it can affect logistics, raw material access and local regulation. Red Flags reluctance to name the manufacturing site licences or certificates that do not match the site or product a CoA that looks generic or does not match the batch prices far below the market with no explanation vague answers on impurities, stability or sourcing refusal of samples, audits or document requests Frequently Asked Questions How do I verify an Indian API manufacturer?Check the manufacturing licence and GMP certificate, confirm the site on the CoA, review inspection history, test samples and consider an audit. Is WHO-GMP enough?It is a strong starting point, but also review quality systems, inspection history, documentation and your own testing results. What is the difference between a manufacturer and a trader?A manufacturer makes the API at its own site. A trader buys from manufacturers and resells. Ask for the manufacturing site details either way. Should I audit before ordering?For critical or high-risk APIs, yes. For lower-risk products, a document review and sample testing may be enough, depending on your quality system. Looking for an API manufacturer in India?See our API products or contact our export team. Sources Pharmexcil handbook (June 2025): bulk drug exports in FY2024-25 BioSpectrum India, India Inching Towards API Self-Reliance

Highly potent active pharmaceutical ingredients (HPAPIs) are APIs that produce a strong biological effect at very low doses. That same strength makes them hazardous to handle. HPAPI manufacturing needs specialised containment, equipment and procedures to protect workers, prevent cross-contamination and keep the product safe. This guide explains what HPAPIs are, why they matter in oncology, how they are manufactured safely, and what buyers should ask suppliers. Key Takeaways HPAPIs are active at very low doses, and exposure to even tiny amounts can harm workers. Many oncology APIs are cytotoxic or highly potent. Safe HPAPI manufacturing relies on containment, dedicated or segregated areas, trained staff and validated cleaning. Buyers should ask how a supplier classifies potency, controls exposure and prevents cross-contamination.   Overview of the Process For a typical synthetic API, the flow looks like this: Process design and route selection Raw material and starting material qualification Chemical synthesis through intermediates Isolation and purification Drying and size reduction Quality control testing Packaging, labelling and release What Is an HPAPI? There is no single universal definition. In industry, an API is usually treated as highly potent when it is active at a very low dose or has a very low occupational exposure limit (OEL). A commonly used guide is an OEL of around 10 micrograms per cubic metre of air or lower, though companies and regulators use different criteria and the classification is based on a toxicological assessment of each compound. HPAPIs include certain cytotoxic agents, some hormones, and other compounds that act at very low doses. Why HPAPIs Matter in Oncology Many cancer medicines are designed to damage or block rapidly dividing cells, so they are highly potent by nature. That is why oncology APIs are the best-known HPAPI group. Not every oncology API is an HPAPI, but many require HPAPI-style controls.z Occupational Exposure Bands Many companies classify compounds into occupational exposure bands (OEBs), which group substances by hazard and set the level of containment required. The higher the band, the tighter the containment. The exact band system and limits vary by company, so ask a supplier how it classifies each product. How HPAPIs Are Manufactured Safely Containment Containment means keeping the compound inside a controlled environment. Typical measures include: closed processing and contained transfer of powders isolators or other containment devices for weighing, charging and sampling ventilation with filtration and controlled air pressure Facility design dedicated or well-segregated production areas and equipment air-handling systems that prevent air from carrying the compound to other areas controlled movement of people, materials and waste People and procedures trained operators and protective equipment suited to the hazard written procedures for handling, spills and emergencies monitoring of exposure where required Cleaning and waste validated cleaning to prevent carryover between products controlled deactivation and disposal of waste Quality and GMP HPAPIs must also meet normal API quality standards. Note that ICH Q7 focuses on product quality and does not cover personnel safety, so worker protection is addressed separately. See GMP in pharmaceutical manufacturing. What Buyers Should Ask an HPAPI Supplier How do you classify the potency of this compound, and what is the basis? What containment measures are used for this product? Is production dedicated or segregated, and how is cross-contamination prevented? How is cleaning validated? How do you protect workers and manage waste? What GMP certification and inspection history do you have? What packaging, labelling and transport safety information do you provide, including the Safety Data Sheet? For a broader checklist, see how to evaluate a pharmaceutical API supplier. HPAPIs at Salvavidas Pharma Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India, with products including oncology APIs. See our oncology API manufacturer page. Frequently Asked Questions What does HPAPI stand for?Highly potent active pharmaceutical ingredient. Are all cytotoxic drugs HPAPIs?Most cytotoxic APIs are treated as highly potent, but classification depends on the toxicological assessment of each compound. Why is HPAPI manufacturing expensive?Containment equipment, dedicated or segregated facilities, specialised training and validated cleaning all add cost. Is an HPAPI dangerous to patients?When made and used correctly, HPAPI medicines are safe and effective. The hazard is mainly to workers and to other products if contamination occurs. Need oncology or potent APIs?Contact our export team with your molecule, grade and quantity.

The API manufacturing process turns raw chemicals into a pure, tested active ingredient that can be used to make medicines. It is a multi-step operation that combines chemistry, engineering and strict quality control, and every stage affects the purity and consistency of the final product. This guide walks through the main stages of API manufacturing, the controls at each step, and the points buyers should understand when evaluating a supplier. Key Takeaways Most synthetic APIs are made in several chemical steps, through intermediates, then isolated, purified, dried and tested. GMP expectations for APIs (ICH Q7) apply from the API starting material onward. Impurities, residual solvents and physical properties are controlled at every stage. Process knowledge, not just equipment, is what gives batch-to-batch consistency.   Overview of the Process For a typical synthetic API, the flow looks like this: Process design and route selection Raw material and starting material qualification Chemical synthesis through intermediates Isolation and purification Drying and size reduction Quality control testing Packaging, labelling and release Step 1: Process Design and Route Selection Before production, chemists choose a synthetic route, meaning the sequence of reactions that leads to the API. A good route is safe, reproducible, cost-effective and produces few difficult impurities. This work is done in pharmaceutical R&D and process development. Step 2: Raw Materials and Starting Materials Manufacturers qualify the suppliers of raw materials, solvents and starting materials, and test incoming materials against specifications. The API starting material is the point from which GMP expectations for API manufacturing formally apply, as set out in ICH Q7 and agreed with regulators. Step 3: Chemical Synthesis Reactions are carried out in reactors under controlled temperature, pressure, time and mixing. Each stage produces an intermediate that may be tested before moving on. In-process checks confirm that a reaction is complete and that key impurities are within limits. Learn more about pharmaceutical intermediates. Step 4: Isolation and Purification After the final reaction, the API is separated from the reaction mixture. Common techniques include: crystallisation to form a pure solid filtration and washing to remove impurities and solvents extraction or chromatography where needed Crystallisation conditions also affect the physical form of the API, such as its crystal form (polymorph) and particle shape. Step 5: Drying and Size Reduction The wet solid is dried to reduce solvents and moisture to the specified limits. Some APIs are then milled or micronised to reach a target particle size, which can affect how the finished tablet dissolves. Step 6: Quality Control Testing A quality control laboratory tests the API against its specification. Typical tests include: assay (strength) and identification related substances (impurities) residual solvents water content physical tests such as particle size and appearance microbial limits, where required Results are recorded on the Certificate of Analysis. See what a CoA is. Step 7: Packaging and Release The approved API is packed in suitable containers, labelled and stored under defined conditions. The quality unit reviews batch records and test results before releasing the batch. Controls That Run Through the Whole Process GMP and quality systems: documentation, change control, deviation handling and data integrity. See GMP in pharmaceutical manufacturing. Cross-contamination control: especially important for potent products. See HPAPI manufacturing. Process validation: showing that the process consistently gives an API that meets specification. Stability studies: confirming how long the API stays within specification. Other Types of API Manufacturing Not all APIs are made by chemical synthesis. Fermentation-derived APIs use microorganisms, plant-derived APIs are extracted and purified from plants, and biological APIs are produced in living cells. Each follows a different process but the same quality principles. What Buyers Should Take Away When evaluating a supplier, ask who runs each step, where the API starting material comes from, how impurities are controlled and what data supports consistency. See how to evaluate a pharmaceutical API supplier. Frequently Asked Questions How long does API manufacturing take?It depends on the number of synthetic steps, the scale and the testing required. Some processes take days, others weeks. Ask your supplier for typical lead times. What is the most important stage?No single stage works alone. Consistency depends on controlling the whole process, but isolation, purification and quality control are especially critical for purity. What does GMP require for APIs?ICH Q7 sets out GMP expectations from the API starting material onward, including quality management, documentation, equipment, production controls and laboratory controls. Why are some APIs more complex to make?More reaction steps, sensitive chemistry, difficult impurities and safety requirements all add complexity, as with many oncology APIs. Looking for a reliable API supplier?See our API products or contact our export team.